Skip to main content

Table 4 GLUL polymorphism rs10911021 and characteristics of subjects among the studied groups

From: GLUL rs10911021 polymorphism and risk of coronary artery disease among Egyptian individuals

  CAD with T2DM (N = 240) CAD (N = 180)
T (%) C (%) p value T (%) C (%) p value
Height (cm) 164.9 ± 9.9 167.9 ± 10 0.047* 168.24 ± 7.5 170.4 ± 7.4 0.064
Weight (kg) 91.49 ± 10.4 90.04 ± 12.6 0.42 99.89 ± 14 93.26 ± 9 0.002**
Waist (cm) 113.38 ± 9.6 107.66 ± 11 < 0.001** 107.82 ± 12 100.5 ± 11.3 < 0.001*
BMI (kg/m2) 33.7579 ± 4 32.0069 ± 4 0.004** 35.4 ± 5.4 32.3 ± 4.2 < 0.001*
SBP (mmHg) 151.08 ± 18 140.44 ± 15 < 0.001** 155 ± 18 145.97 ± 15 0.001**
DBP (mmHg) 94.85 ± 15 86.41 ± 10 < 0.001** 97.45 ± 15 90.48 ± 11 0.002**
FBS (mg/dL) 202.02 ± 49 210.70 ± 62 0.323 94.04 ± 21 92.8 ± 21.5 0.711
2HPP (mg/dL) 236.308 ± 70 249.437 ± 88 0.258 101.63 ± 20 100 ± 19.3 0.646
HbA1c % 8.3077 ± 1.5 8.3511 ± 1.5 0.85 5.761 ± 0.8 5.6 ± 0.74 0.055
CHOL (mg/dL) 220.462 ± 49 201.852 ± 52 0.017* 227.4 ± 65 202.78 ± 58 0.01*
TG (mg/dL) 184.015 ± 35 196.230 ± 87 0.161 183.61 ± 61 166.58 ± 64 0.091
HDL (mg/dL) 31.677 ± 7.5 35.859 ± 9.0 0.002** 33.14 ± 9.5 33.19 ± 9.2 0.974
LDL (mg/dL) 152 ± 51.5 124.519 ± 47 < 0.001** 157.07 ± 61 135.17 ± 56 0.017*
CRP (mg/L) 124.7 ± 55 113.7 ± 61 0.221 129.82 ± 42 116.8 ± 47 0.076
INS (mIU/L) 10.8 ± 28 11.58 ± 23.0 0.828 12.18 ± 16 14.6 ± 16.7 0.34
PON1 (mIU/mL) 22.75 ± 7.2 27.3 ± 14 0.021* 25.87 ± 6 25.8 ± 8 0.993
  1. CAD with T2DM CAD with type 2 diabetes mellitus, CAD coronary artery diseases, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FBS fasting blood sugar, 2HPP 2 h post prandial, HbA1c hemoglobin A1c (glycated hemoglobin), CHOL cholesterol, TG triglyceride, HDL high-density lipoprotein, LDL low-density lipoprotein, CRP c-reactive protein, INS insulin, PON1 paraoxonase 1
  2. *The mean difference is significant at the 0.05 level (two-tailed)
  3. **The mean difference is highly significant at the 0.01 level (two-tailed)